May 8, 2006

Lonza increases Niacin and Niacinamide prices
 

Press release
 

Lonza has announced a worldwide price increase of 8 to 10 percent for feed grade Niacin and Niacinamide due to continued price increases of raw materials and energy costs.

The price increase will come into effect on Jul 1, 2006.

Lonza, a chemical and biotechnology company driven by the life sciences, generated sales of CHF 2.52 billion in 2005. Headquartered in Switzerland, Lonza operates 22 production and R&D sites around the world. Its 6,300 employees are committed to delivering sustainable value to their customers. Lonza is one of the leading custom manufacturers of chemical intermediates, active ingredients and biopharmaceuticals for the pharmaceutical and agrochemical industries. On the basis of organic and performance chemical and biotechnology platforms, Lonza creates value-added solutions for the nutrition, hygiene and personal care, wood and water treatment, and industrial specialty markets. The company also offers polymer intermediates, resins and compounds, and is listed on the SWX Swiss Exchange. Further information can be found on the website: www.lonza.com

For further information, contact:

Ernesto Plozza                                                   Margot Connor

Business Unit Nutrition                                       Corporate Communications

Tel: +41-61-316-8638                                       Tel: +41-61-316-8566

Fax: +41-61-316-9638                                       Fax: +41-61-316-9566

E-mail: ernesto.plozza@lonza.com                       E-mail: margot.connor@lonza.com